Elaine Blais, head of the Litigation Department in Goodwin’s Boston office, focuses her practice on intellectual property litigation, particularly with respect to patent litigation. Ms. Blais has handled numerous patent infringement lawsuits in federal courts nationwide. She serves on Goodwin’s Intellectual Property Steering and Attorney Development Committees. Ms. Blais is the co-founder and editor of the firm’s biosimilars blog, www.bigmoleculewatch.com, which is dedicated to providing resources and observations through Goodwin’s active watch of the world of biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA). She is the former co-chair of the Boston Women's Initiative Council. Having served on various committees across the firm, Ms. Blais is currently Co-Chair of our Incubator Committee, which guides the growth and development of emerging and innovative practices.





Ms. Blais has been litigating patent cases for nearly 25 years. She has advised clients and participated in all phases of patent litigation, from initial counseling up through trial and appeal. Ms. Blais has worked on patent cases involving diverse areas of technology, including pharmaceutical products (Teva Pharmaceuticals, Fresenius Kabi, Hikma, Dr. Reddy’s), biosimilars (Celltrion, Association for Accessible Medicines, Boehringer Ingelheim), stem cell technology (ViaCell, Inc.), secure financial transactions (Fidelity), prepaid wireless technology (Freedom Wireless), email tracking systems (Eloqua), semiconductor manufacturing tools (Applied Materials), and consumer products (P&G).

In addition to her patent litigation experience, she has represented clients in cases involving copyrights, trademarks, trade secrets, unfair competition and patent-related antitrust issues. Ms. Blais has also filed amicus briefs on behalf of firm clients in a number of significant patent cases before the U.S. Supreme Court and the Federal Circuit sitting en banc, including Therasense v. Becton Dickinson, Microsoft v. i4i, and Caraco v. Novo Nordisk.

Ms. Blais has devoted a significant amount of her practice to counseling clients and advocating to Congress on behalf of clients regarding patent policy. In this capacity, she has worked on various pieces of legislation impacting the pharmaceutical industry, including the Biologics Price Competition & Innovation Act and the America Invents Act. Ms. Blais has been involved in drafting proposed legislation and has made numerous presentations before Congressional members and staff.

Additionally, Ms. Blais has an active pro bono practice. Since 2012, she has represented unaccompanied immigrant and refugee children in their deportation proceedings through Kids in Need of Defense (KIND). Since 2008, she has also represented adults seeking asylum through The Political Asylum/Immigration Representation Project (PAIR) and has recently represented Ugandan lesbians through Immigration Equality, which provides legal counsel to the LGBT and HIV-positive immigrant community. With the Lawyers’ Committee for Civil Rights and Economic Justice, Ms. Blais is involved in the support of Massachusetts sanctuary cities Chelsea and Lawrence, seeking to establish that these cities are in full compliance with federal immigration law.

Professional Activities

Ms. Blais currently serves on the KIND Boston Advisory Committee and as a council member for the Boston Bar Association.

In 2013, at the selection of firm leadership, Ms. Blais participated in Harvard Business School’s “Leading Professional Service Firms” executive education program. This selective program focuses on how professional service firms should approach client retention and client service, among other critical issues facing professional service firms.

In 2011, Ms. Blais was selected by the firm to participate in LEAD Boston, a year-long program focused on leadership and social justice.

Ms. Blais is a member of the American Bar Association, the Boston Bar Association, and the American Intellectual Property Law Association.


Ms. Blais was recognized in The Best Lawyers in America 2021 for her work in Litigation – Patent.

Ms. Blais was included as an IP Star for Massachusetts in the 2020/21 by Managing IP. Patexia named Ms. Blais as a top ANDA litigator in 2020. 

Ms. Blais is regularly recognized by leading industry publications, including Managing Intellectual Property’s “IP Star,” Legal 500 (Patent Litigation), and LMG Life Sciences “Life Sciences Stars.”

In 2018 and 2019, Ms. Blais was on the shortlist for LMG Life Sciences’ General Patent Litigator of the Year: New England.

In 2017, Ms. Blais was honored for her commitment to community and pro bono work with the Boston Bar Association’s Thurgood Marshall Award, presented annually to a lawyer in Greater Boston for extraordinary efforts in enhancing the human dignity of others through improving or delivering services to Massachusetts’ low income population.

In 2012, Ms. Blais and a client were selected as a recipient of the Project for Attorney Retention’s 2012 PAR Flex Success Award. The award recognizes attorney-client relationships exemplifying how, with client and firm support, attorneys can work on flexible schedules, deliver exceptional legal services and enjoy extraordinarily successful careers.

In 2009, Ms. Blais was awarded the Mentor Award from the Political Asylum/Immigration Representation Project for her work on behalf of human rights and immigrant advocacy. Ms. Blais continues to dedicate pro bono time to the representation of immigrants seeking asylum, refugee status or special immigrant juvenile status in the United States. While attending law school, Ms. Blais was an associate editor of The Ohio State Law Journal.

In The News









J.D., 1995
The Ohio State University, College of Law

(with honors, Order of the Coif)

B.A., 1991
Allegheny College





U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the First Circuit
U.S. District Court for the District of Massachusetts
U.S. District Court for the Eastern District of Texas
U.S. District Court for the Northern District of Ohio
U.S. District Court for the Northern District of Illinois
U.S. District Court for the Eastern District of Michigan
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique